mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.4 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.4 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.4 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |